In 2023, the re-import of carboxyamid-function compounds to China was valued at a significant level, indicating a robust baseline. From 2024 to 2028, forecasts reveal a consistent declining trend in the re-import market, with values dropping steadily each year. Specifically, the annual percentage decreases are substantial, with a year-on-year decline ranging from approximately 11.9% in 2025 to 17.1% by 2028. The Compound Annual Growth Rate (CAGR) over this five-year forecast period projects an average negative growth, highlighting a shrinking market.
As we look to the future, key trends to monitor include potential shifts in China’s domestic production capabilities, global supply chain adjustments, and regulatory changes that could influence the market dynamics of carboxyamid-function compounds. Additionally, technological advancements and alternative material developments could further impact demand and re-import levels.
